• Loading stock data…

Bio-Thera Solutions Announces First Patient Dosed in Australia for BAT6021, an ADCC-enhanced Monoclonal Antibody Targeting TIGIT for the Treatment of Solid Tumors

[#item_full_content]

Print Friendly, PDF & Email
Spread the word